Emma Scott

Associate Professor

  • 3243 Citations
  • 11 h-Index
20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3243 Citations
  • 11 h-Index
  • 17 Article
  • 2 Letter
  • 2 Review article
Filter
Article
2019

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Gandhi, U. H., Cornell, R. F., Lakshman, A., Gahvari, Z. J., McGehee, E., Jagosky, M. H., Gupta, R., Varnado, W., Fiala, M. A., Chhabra, S., Malek, E., Mansour, J., Paul, B., Barnstead, A., Kodali, S., Neppalli, A., Liedtke, M., Narayana, S., Godby, K. N., Kang, Y. & 9 others, Kansagra, A., Umyarova, E., Scott, E. C., Hari, P., Vij, R., Usmani, S. Z., Callander, N. S., Kumar, S. K. & Costa, L. J., Sep 1 2019, In : Leukemia. 33, 9, p. 2266-2275 10 p.

Research output: Contribution to journalArticle

Open Access
16 Scopus citations

Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma

Gopalakrishnan, S., D'Souza, A., Scott, E., Fraser, R., Davila, O., Shah, N., Gale, R. P., Kamble, R., Diaz, M. A., Lazarus, H. M., Savani, B. N., Hildebrandt, G. C., Solh, M., Freytes, C. O., Lee, C., Kyle, R. A., Usmani, S. Z., Ganguly, S., Assal, A., Berdeja, J. & 14 others, Kanate, A. S., Dhakal, B., Meehan, K., Kindwall-Keller, T., Saad, A., Locke, F., Seo, S., Nishihori, T., Gergis, U., Gasparetto, C., Mark, T., Nieto, Y., Kumar, S. & Hari, P., Apr 2019, In : Biology of Blood and Marrow Transplantation. 25, 4, p. 683-688 6 p.

Research output: Contribution to journalArticle

3 Scopus citations
2018

Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity

Heitner, S. B., Minnier, J., Naher, A., Van Woerkom, R. C., Ritts, A., Ferencik, M., Broberg, C., Medvedova, E., Silbermann, R. & Scott, E. C., Dec 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 12, p. 796-802 7 p.

Research output: Contribution to journalArticle

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: Updated analysis of CASTOR

Spencer, A., Lentzsch, S., Weisel, K., Avet-Loiseau, H., Mark, T. M., Spicka, I., Masszi, T., Lauri, B., Levin, M. D., Bosi, A., Hungria, V., Cavo, M., Lee, J. J., Nooka, A. K., Quach, H., Lee, C., Barreto, W., Corradini, P., Min, C. K., Scott, E. C. & 17 others, Chanan-Khan, A. A., Horvath, N., Capra, M., Beksac, M., Ovilla, R., Jo, J. C., Shin, H. J., Sonneveld, P., Soong, D., Casneuf, T., Chiu, C., Amin, H., Qi, M., Thiyagarajah, P., Sasser, A. K., Schecter, J. M. & Mateos, M. V., Nov 30 2018, In : Haematologica. 103, 12, p. 2079-2087 9 p.

Research output: Contribution to journalArticle

58 Scopus citations

Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups

Scott, E. C., Hari, P., Kumar, S., Fraser, R., Davila, O., Shah, N., Gale, R. P., Diaz, M. A., Agrawal, V., Cornell, R. F., Ganguly, S., Akpek, G., Freytes, C., Hashmi, S., Malek, E., Kamble, R. T., Lazarus, H., Solh, M., Usmani, S. Z., Kanate, A. S. & 16 others, Saad, A., Chhabra, S., Gergis, U., Cerny, J., Kyle, R. A., Lee, C., Kindwall-Keller, T., Assal, A., Hildebrandt, G. C., Holmberg, L., Maziarz, R. T., Nishihori, T., Seo, S., Kumar, S., Mark, T. & D'Souza, A., Dec 2018, In : Biology of Blood and Marrow Transplantation. 24, 12, p. 2443-2449 7 p.

Research output: Contribution to journalArticle

5 Scopus citations
2017

Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma

Saraceni, M. M., Scott, E., Maziarz, R., Siegel, M. B., Bassale, S., Jiing, S. & Medvedova, E., Jan 1 2017, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): An open-label, randomised, phase 2 trial

Lonial, S., Weiss, B. M., Usmani, S. Z., Singhal, S., Chari, A., Bahlis, N. J., Belch, A., Krishnan, A., Vescio, R. A., Mateos, M. V., Mazumder, A., Orlowski, R. Z., Sutherland, H. J., Bladé, J., Scott, E. C., Oriol, A., Berdeja, J., Gharibo, M., Stevens, D. A., Leblanc, R. & 12 others, Sebag, M., Callander, N., Jakubowiak, A., White, D., De La Rubia, J., Richardson, P. G., Lisby, S., Feng, H., Uhlar, C. M., Khan, I., Ahmadi, T. & Voorhees, P. M., Apr 9 2016, In : The Lancet. 387, 10027, p. 1551-1560 10 p.

Research output: Contribution to journalArticle

386 Scopus citations

Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., Dhodapkar, M., Avigan, D., Chapuy, B., Ligon, A. H., Freeman, G. J., Rodig, S. J., Cattry, D., Zhu, L., Grosso, J. F., Brigid Bradley Garelik, M. & 3 others, Shipp, M. A., Borrello, I. & Timmerman, J., Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2698-2704 7 p.

Research output: Contribution to journalArticle

431 Scopus citations

Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis

Scott, E. C., Hari, P., Sharma, M., Le-Rademacher, J., Huang, J., Vogl, D., Abidi, M., Beitinjaneh, A., Fung, H., Ganguly, S., Hildebrandt, G., Holmberg, L., Kalaycio, M., Kumar, S., Kyle, R., Lazarus, H., Lee, C., Maziarz, R. T., Meehan, K., Mikhael, J. & 13 others, Nishihori, T., Ramanathan, M., Usmani, S., Tay, J., Vesole, D., Wirk, B., Yared, J., Savani, B. N., Gasparetto, C., Krishnan, A., Mark, T., Nieto, Y. & D'Souza, A., Oct 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 10, p. 1893-1899 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
2015

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

Uy, G. L., Costa, L. J., Hari, P. N., Zhang, M. J., Huang, J. X., Anderson, K. C., Bredeson, C. N., Callander, N. S., Cornell, R. F., Perez, M. A. D., Dispenzieri, A., Freytes, C. O., Gale, R. P., Garfall, A., Gertz, M. A., Gibson, J., Hamadani, M., Lazarus, H. M., Kalaycio, M. E., Kamble, R. T. & 32 others, Kharfan-Dabaja, M. A., Krishnan, A. Y., Kumar, S. K., Kyle, R. A., Landau, H. J., Lee, C. H., Maiolino, A., Marks, D. I., Mark, T. M., Munker, R., Nishihori, T., Olsson, R. F., Ramanathan, M., Rodriguez, T. E., Saad, A. A., Savani, B. N., Schiller, G. J., Schouten, H. C., Schriber, J. R., Scott, E., Seo, S., Sharma, M., Ganguly, S., Stadtmauer, E. A., Tay, J., To, L. B., Vesole, D. H., Vogl, D. T., Wagner, J. L., Wirk, B., Wood, W. A. & D'Souza, A., Dec 1 2015, In : Bone marrow transplantation. 50, 12, p. 1513-1518 6 p.

Research output: Contribution to journalArticle

Open Access
20 Scopus citations

Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: A center for international blood and marrow transplant research study

D'Souza, A., Dispenzieri, A., Wirk, B., Zhang, M. J., Huang, J., Gertz, M. A., Kyle, R. A., Kumar, S., Comenzo, R. L., Gale, R. P., Lazarus, H. M., Savani, B. N., Cornell, R. F., Weiss, B. M., Vogl, D. T., Freytes, C. O., Scott, E. C., Landau, H. J., Moreb, J. S., Costa, L. J. & 10 others, Ramanathan, M., Callander, N. S., Kamble, R. T., Olsson, R. F., Ganguly, S., Nishihori, T., Kindwall-Keller, T. L., Wood, W. A., Mark, T. M. & Hari, P., Nov 10 2015, In : Journal of Clinical Oncology. 33, 32, p. 3741-3749 9 p.

Research output: Contribution to journalArticle

100 Scopus citations

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., Rodig, S. J., Chapuy, B., Ligon, A. H., Zhu, L., Grosso, J. F., Kim, S. Y., Timmerman, J. M., Shipp, M. A. & Armand, P., Jan 22 2015, In : New England Journal of Medicine. 372, 4, p. 311-319 9 p.

Research output: Contribution to journalArticle

1906 Scopus citations
Open Access
31 Scopus citations
2014

Combined autophagy and proteasome inhibition a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

Vogl, D. T., Stadtmauer, E. A., Tan, K. S., Heitjan, D. F., Davis, L. E., Pontiggia, L., Rangwala, R., Piao, S., Chang, Y. C., Scott, E. C., Paul, T. M., Nichols, C. W., Porter, D. L., Kaplan, J., Mallon, G., Bradner, J. E. & Amaravadi, R. K., Aug 2014, In : Autophagy. 10, 8, p. 1380-1390 11 p.

Research output: Contribution to journalArticle

Open Access
183 Scopus citations

Induction bortezomib in AL amyloidosis followed by high dose melphalan and autologous stem cell transplantation: A single institution retrospective study

Scott, E. C., Heitner, S. B., Dibb, W., Meyers, G., Smith, S. D., Abar, F., Kovacsovics, T., Perez-Avraham, G., Stentz, A., Frires, R., Dibb, J. & Maziarz, R. T., Oct 1 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 5, p. 424-430.e1

Research output: Contribution to journalArticle

19 Scopus citations

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Sharma, M., Zhang, M. J., Zhong, X., Abidi, M. H., Akpek, G., Bacher, U., Callander, N. S., Dispenzieri, A., Freytes, C. O., Fung, H. C., Gale, R. P., Gasparetto, C., Gibson, J., Holmberg, L. A., Kindwall-Keller, T. L., Klumpp, T. R., Krishnan, A. Y., Landau, H. J., Lazarus, H. M., Lonial, S. & 16 others, Maiolino, A., Marks, D. I., Mehta, P., Mikhael Med, J. R., Nishihori, T., Olsson, R., Ramanathan, M., Roy, V., Savani, B. N., Schouten, H. C., Scott, E., Tay, J., To, L. B., Vesole, D. H., Vogl, D. T. & Hari, P., Nov 1 2014, In : Biology of Blood and Marrow Transplantation. 20, 11, p. 1796-1803 8 p.

Research output: Contribution to journalArticle

Open Access
51 Scopus citations
2011

Plummer-Vinson syndrome and reactive thrombocytosis mask a JAK2-V617F positive myeloproliferative neoplasm

Scott, E. C. & Schuster, S., Dec 1 2011, In : Blood. 118, 23, 1 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations